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 Summary
The first case of a female neonate born from an in vitro fertilization with embryo transfer (IVF-ET) and 
intracytoplasmic sperm injection (ICSI) (IVF-ET (ICSI) with two histologically different tumours (craniopharyngioma 
and hepatoblastoma) is described. Anti-neoplasmatic therapy was abandoned due to the significant extent of 
the disease (craniopharyngioma, 15×12 cm in diameter with active internal hydrocephalus; and right liver lobe 
hepatoblastoma, 5 cm in diameter) and the severely impaired general condition of the neonate. The neonate died 
on the 30th day of life due to cerebellar and brainstem herniation, followed by circulatory and respiratory failure. 
 Key words: newborn / in	vitro	fertilization / craniopharyngioma / hepatoblastoma /  
 Streszczenie
Przedstawiono Opisano pierwszy przypadek noworodka urodzonego w następstwie zapłodnienia pozaustrojowego 
(IVF-ET ICSI) z dwoma różnymi histologicznie guzami nowotworowymi (craniopharyngioma and hepatoblastoma). 
Ze względu na stopień zaawansowania choroby (craniopharyngioma, 15x12 cm z aktywnym wodogłowiem 
wewnętrznym; hepatoblastoma o średnicy 5,0 cm) i niewydolność wielonarządową po urodzeniu nie podjęto 
leczenia przeciw-nowotworowego, ograniczono się jedynie do leczenia paliatywnego. Zgon nastąpił w 30 dobie 
życia, wśród objawów niewydolności oddechowo-krążeniowej.
 Słowa kluczowe: noworodek / zapłodnienie in vitro / craniopharyngioma / 
                   / hepatoblastoma /  
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Introduction 
Foetal	and	neonatal	neoplasms	are	rare,	with	an	incidence	of	
1	in	12,000-27,500	live	births	[1,	2].	Most,	but	not	all,	childhood	
neoplasms	occur	during	the	perinatal	period	[1].	
The	 aetiology	 of	 cancer	 in	 children	 is	 multifactorial,	 and	
includes	both	genetic	and	environmental	factors.	The	association	
between	congenital	abnormalities	and	tumours	is	well-established	
[1,	 3].	 Certain	 constitutional	 chromosome	 abnormalities	
specifically	favour	tumours	occurring	in	the	foetal	and	neonatal	
periods	 [2].	 Other	 environmental	 associations	 include	 ionizing	
radiation,	drugs	 taken	during	pregnancy,	 infections,	 tumours	 in	
the	mother,	and	environmental	exposure	[2].	A	number	of	authors	
have	suggested	the	possibility	of	an	association	between	in vitro 
fertilization	(IVF)	and	the	presence	of	some	histologic	types	of	
tumours	 in	 children,	 such	 as	 embryonal	 and	 neuroectodermal	
tumours,	neuroblastomas,	and	retinoblastomas	[4,	5].	The	advent	
of	foetal	ultrasound	and	magnetic	resonance	imaging	has	resulted	
in	more	frequent	descriptions	of	antenatal	tumours	[4,	5].	Brain	
and	 liver	 tumours	 are	 among	 the	 most	 frequent	 neoplasms	
diagnosed	by	prenatal	ultrasound.	
Central	nervous	system	neoplasms	comprise	 the	fifth	most	
frequent	 group	 of	 neonatal	 tumours,	 as	 follows:	 astrocytomas,	
36.9%;	 medulloblastomas,	 16%;	 pineal	 region	 neoplasms,	
6.7%;	 neuroblastomas,	 6%;	 craniopharyngiomas,	 6%;	 and	
ependimomas,	47%.	Craniopharyngiomas	are	benign	neoplasms	
of	epithelial	origin;	however,	benign	tumours	may	also	be	life-
threatening	because	of	their	size	and	location	[2].	
Primary	 liver	 tumours	 comprise	 approximately	 5%	 of	 all	
foetal	 and	 neonatal	 neoplasms.	 Hepatoblastomas	 are	 the	 most	
frequent	type	of	liver	malignancies	in	children	up	to	5	years	of	
age.	Less	than	10%	of	tumors	present	during	the	neonatal	period	
[6,	7].	
The	 number	 of	 children	 born	 as	 a	 result	 of	 advanced	
hormonal	therapy	for	ovulation	and	spermatogenesis	and	assisted	
reproductive	 technology	 (ART)	 has	 increased	 in	 recent	 years	
[8].	Reports	on	embryonal	tumours	of	the	CNS,	liver,	and	bone	
marrow	 in	 foetuses	and	newborns	 from	ART	pregnancies	have	
been	reported	[4,	9].	Unfortunately,	 there	are	no	epidemiologic	
studies	which	have	assessed	the	risk	of	neoplasia	in	foetuses	and	
newborns	born	from	ART	pregnancies.
Case report 
A	female	neonate	was	born	to	a	healthy	35-year-old	mother	
and	 a	 healthy	 37-year-old	 father	 with	 	 no	 family	 history	 of	
neoplasia.	 The	 mother	 had	 been	 treated	 for	 several	 years	 for	
infertility.	 The	 first	 IVF	 attempt	 resulted	 in	 a	 spontaneous	
abortion	at	8	weeks	gestation.	The	newborn	was	born	from	the	
second	 pregnancy,	 which	 was	 achieved	 with	 IVF	 and	 embryo	
transfer	 (ET)	 with	 intracytoplasmic	 sperm	 injection	 (ICSI).	
Before	 and	 during	 the	 ICSI	 procedure	 the	 mother	 was	 given	
the	 following	 medications,	 according	 to	 the	 recommended	
protocol:	Triptorelina,	 Follitropin	 recombinant,	Menotropinum,	
Chorionic	gonodotropin,	Linestrenol,	Estradiol,	Nadroparine	and	
Acetylosalicylic	acid.
At	 35	 weeks	 gestation ultrasound	 and	 MRI	 foetal	 scan	
revealed	 the	 presence	 of	 internal	 hydrocephalus	 and	 tumour	
lesions	affecting	the	entire	cerebral	hemispheres	bilaterally.	The	
foetus	was	delivered	at	37	weeks	gestation	by	caesarean	section	
due	to	cephalo-pelvic	disproportion.	
The	birth	weight	 	was	3550g,	 the	head	circumference	was	
46.5	cm,	and	the	Apgar	score	at	5	minutes	was	6. A MRI	repeated	
postnatally	confirmed	the	presence	of	a	15×12cm	cerebral	tumour	
with	calcified	foci	characteristic	of	a	craniopharyngioma	(Figure	
1A).	
The	maximum	alpha	foetoprotein	level	was	3,184,000	IU/l.	
The	 newborn	 required	 an	 incubator	 environment	 and	 passive	
oxygen	therapy.	
From	the	2nd	day	of	life,	an	exacerbated	jaundice	with	normal	
liver	 function	 tests.	 The	 neonate	 did	 not	 tolerate	 oral	 feeding	
and	developed	 significant	 abdominal	 distension.	An	 abdominal	
ultrasound	 revealed	 the	 presence	 of	 a	 solid,	 heterogeneous,	
well-delineated	tumour,	5.0cm	in	diameter,	affecting	the	III	and	
IV	 segments	with	 an	 irregular	hypoechogenic	 focus	 that	 likely	
represented	necrosis	within	the	tumour	(Figure	1B).	
A	 chest	 X-ray	 and	 heart	 ultrasound	 were	 normal.	A	 liver	
biopsy	was	not	attempted	at	the	request	of	the	parents.	
The	 severe	 general	 condition	 of	 the	 newborn	 and	 the	
progressive	cardio-respiratory	distress	were	contraindications	for	
chemotherapy.	The	newborn	died	on	the	30th	day	of	 life	due	to	
a	 generalized	 neoplastic	 process	with	 symptoms	 of	 respiratory	
and	 circulatory	 failure.	 The	 autopsy	 listed	 the	 direct	 cause	 of	
death	as	cerebellar	and	brainstem	herniation.	A	histopathologic	
examination	 confirmed	 the	 presence	 of	 two	 histologically	
different	tumours	(craniopharyngioma	and	hepatoblastoma).	
On	 gross	 examination,	 the	 craniopharyngioma	 occupied	
the	base	of	the	brain	and	presented	as	a	large,	15	x	12cm	cystic	
tumor.	 Histologically,	 squamous	 epithelium	 with	 a	 palisading	
arrangement	of	cells	at	the	periphery	of	the	cell	nest	was	noted.	
Masses	 of	 keratin	 and	 calcifications	were	 also	 present	 (Figure	
2A).		
The	hepatoblastoma	appeared	grossly	in	the	liver	as	a	well-
defined	 solid	 tumor,	 5cm	 in	 diameter,	 with	 areas	 of	 necrosis	
and	 hemorrhage	 in	 the	 central	 portion.	 Microscopically,	 the	
hepatoblastoma	was	composed	of	immature	hepatocytes	arranged	
in	irregular	laminae	two	cell	layers	thick.	In	some	areas,	rosettes	
and	a	solid	or	nesting	pattern	was	present	(Figure	2B).		
Discussion 
We	have	presented	the	case	of	a	neonate	born	following	an	
ART	pregnancy	with	two	neoplasms	(a	craniopharyngioma	and	
a	 hepatoblastoma)	 that	 have	 no	 biological	 link.	The	 published	
literature	 with	 data	 on	 the	 general	 incidence	 of	 congenital	
tumours	is	insufficient	to	calculate	the	risk	of	occurrence	of	such	
neoplasms	in	neonates.	
Altman	et	al,	published	the	results	of	a	register-based	case-
control	 study	 that	assessed	 the	 risk	of	children	with	congenital	
malformations	 developing	 cancer	 [3].	The	 report	 confirms	 that	
children	with	congenital	malformations	have	an	increased	risk	of	
various	malignancies.	Das	et	al,	 indicate	a	possible	association	
between	 genetic	 defects	 and	 embryonal	 neoplasms	 in	 foetuses	
conceived	by	IVF.	In	the	described	case,	genetic	and	congenital	
abnormalities	were	not	detected	[5].	
Moore	et	al,	reported	that	neonatal	tumours	comprise	2%	of	
childhood	malignancies	 [2].	A	review	of	 the	 literature	 revealed	
only	4	cases	of	neonatal	brain	 tumours	 in	newborns	born	from	
IVF	pregnancies	[5,	9].	Thus	far,	cases	of	craniopharyngiomas	in	
children	born	after	natural	fertilization	have	been	described	[10].
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As	 in	 our	 case,	 one	 of	 the	 patients	was	 not	 scheduled	 for	
surgery	 due	 to	 her	 serious	 condition,	 which	 is	 the	 method	 of	
choice	in	this	type	of	neoplasm	[10].	
Hepatoblastomas	 are	 rare	 in	 newborns	 born	 from	 IVF	
pregnancies	 [11].	 In	 our	 case,	 the	 hepatoblastoma	 was	 not	
diagnosed	 during	 the	 prenatal	 ultrasound	 examination.	 Moore	
et	al,	concluded	 	 that	majority	of	 tumours	with	a	mass	at	birth	
were	not	identified	on	antenatal	ultrasound	[2].	The	majority	of	
newborns	with	 hepatoblastomas	 are	 scheduled	 for	 surgery	 and	
chemotherapy	 [6,	 9];	 however,	 it	 should	 be	 emphasized	 that	
surgery	 or	 chemotherapy	 are	 only	 appropriate	 for	 newborns	 in	
good	clinical	condition	with	small	tumours.	
We	reported	a	case	involving	a	neonate	with	two	congenital	
neoplasms	born	from	an	ART	pregnancy	to	focus	on	the	precise	
risk	 of	 imprinting	 and	 childhood	 cancer	 from	ART.	 In	 recent	
years,	there	has	been	increasing	concern	regarding	the	safety	of	
IVF	because	of	the	potential	health	impact	on	these	infants	[12].	
Kaira	and	Molinaro,	reported	an	increased	risk	of	congenital	and	
chromosomal		anomalies	after	IVF	[12].	The	association	between	
IVF	and	pediatric	cancer	has	been	described	only	in	sporadic	case	
reports	[4,	5,	9].	Lerner-Geva	et	al,	reviewed	the	medical	records	
of	 332	 children	 from	 1254	 women	 who	 underwent	 IVF	 and	
observed	no	 cancer	 cases	 [13].	However,	 because	of	 the	 small	
cohort	 analysis,	 a	 larger	 prospective	 study	 is	 needed	 to	 assess	
the	potential	carcinogenic	effect	on	children	born	after	ovulation	
induction	and	IVF.	Also,	Bruinsma	et	al,	who	assessed	the	risk	of	
cancer	in	5249	children	born	after	ART	at	2	clinics	in	Victoria,	
Australia,	did	not	observe	a	significantly	increased	incidence	of	
cancer	in	comparison	to	the	general	population	[4].	In	their	study,	
4.33	cases	of	cancer	were	expected	and	6	cases	were	observed.
Allen	et	al,	searched	the	Cochrane	Library	and	MEDLINE	
for	English-language	articles	from	1990-2005	relating	to	assisted	
reproduction	and	perinatal	outcomes,	and	concluded	that	further	
clinical	 research,	 including	 long-term	 follow-up,	 is	 urgently	
required	to	evaluate	 the	prevalence	of	 imprinting	disorders	and	
cancers	 associated	 with	ART	 [14].	 Raimondi	 et	 al,	 conducted	
a	 meta-analysis	 on	 11	 cohort	 studies	 of	ART	 and	 subsequent	
childhood	 cancer,	 and	 concluded	 that	 the	 data	 are	 consistent	
with	a	lack	of	increase	in	risk	of	childhood		cancer,	although	the	
amount	of	data	on	ART	and	cancer	were	limited	[15].		
 
Figure 1A. MRI axial post-contrast T1WI shows a large heterogeneous lesion 
with irregular enhancement. The lesion causes obstructive hydrocephalus involving 
the lateral ventricles. 
 
Figure 2A. Craniopharyngioma with characteristic palisading of tumor cells  
(HE stain, original magnification x200).  
 
Figure 1B. Abdominal ultrasound shows left liver lobe tumour, 5 cm in diameter. 
 
 
Figure 2B. Hepatoblastoma, classical morphology with few rosettes present  
(HE stain, original magnification x200). 
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In	2009,	Felix	et	al,	assessed	a	pooled	analysis	of	48	potential	
sources	of	data	from	existing	cohort	studies	of	children	born	after	
ART	[16].	The	total	number	of	children	enrolled	by	the	studies	
participating	 in	 the	 pooled	 analysis	was	 at	 least	 33,981.	Their	
research	showed	that	the	current	state	of	data		collection	in	most	
countries	is	inadequate	to	fully	address	the	issue	of		the	long-term	
safety	of	ART.	The	present	pooling	effort	includes	expansion	of	
the	 cohort	 of	 children	 born	 after	ART,	 updated	 record	 linkage	
for	 complete	 cancer	 cases	 identification,	 and	 calculation	 of	
standardized	 incidence	 ratios	 stratified	 by	 cause	 of	 infertility,	
socioeconomic	 status,	 and	 hormonal	 regimen	 (as	well	 as	 other	
confounders)	to	assess	the	long-term	health	status	of	children	born	
after	ART	[16].	Thus	we	conclude,	it	is	time	for	an	epidemiologic	
study	of	this	issue.
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